Shanghai, China

Min Rao

USPTO Granted Patents = 1 

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):

Title: Min Rao: Innovator in Glycopeptide Compounds

Introduction

Min Rao is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of glycopeptide compounds that combat drug-resistant bacteria. His innovative work addresses a critical need in modern medicine, especially in the face of rising antibiotic resistance.

Latest Patents

Min Rao holds a patent for glycopeptide compounds that exhibit activity against drug-resistant bacteria. The patent, titled "Glycopeptide compounds having activity of resisting drug-resistant bacteria, and preparation method and application thereof," outlines a novel approach to treating infections caused by resistant strains. The compounds conform to a general formula and have demonstrated higher inhibition activity against drug-resistant bacterial strains, particularly MRSA and VRE, compared to existing treatments like oritavancin. Furthermore, these compounds have shown improved safety profiles, making them suitable for developing drugs aimed at treating various bacterial infections, including skin and soft tissue infections, meningitis, sepsis, pneumonia, arthritis, peritonitis, bronchitis, and empyema.

Career Highlights

Throughout his career, Min Rao has worked with notable companies in the biopharmaceutical sector. He has been associated with Shanghai Laiyi Center for Biopharmaceutical R&D Co., Ltd. and Zhejiang Medicine Co., Ltd. His work in these organizations has contributed to advancements in drug development and research.

Collaborations

Min Rao has collaborated with several professionals in his field, including Chang Shao and Mei Ge. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his work.

Conclusion

Min Rao's innovative contributions to glycopeptide compounds represent a significant advancement in the fight against drug-resistant bacteria. His work not only addresses urgent medical challenges but also paves the way for future developments in antibiotic therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…